A GHRH analog with an albumin-binding Drug Affinity Complex for extended half-life.

| Compound | CJC-1295 DAC |
| Also known as | CJC-1295 with DAC |
| CAS Number | 863288-34-0 |
| Molecular Weight | 3,647.2 g/mol |
| Sequence / Form | Modified GRF(1-29) + Drug Affinity Complex |
| Classification | Endocrine research compound |
| Appearance | Lyophilized powder |
| Purity | ≥99% (HPLC · MS-verified) |
| Storage | 2–8°C; -20°C for long-term |
| Intended Use | Research Use Only |
CJC-1295 with DAC is a modified GHRH(1-29) analog bearing a Drug Affinity Complex (DAC) that binds serum albumin, substantially extending its circulating half-life in research models compared with the no-DAC version.
As a GHRH-receptor agonist it is studied for sustained stimulation of the growth-hormone axis.
Every Ethos Bio lot of CJC-1295 DAC is analyzed by reverse-phase HPLC and independently confirmed by mass spectrometry through our third-party testing partner, Janoshik Analytical. A signed Certificate of Analysis documenting identity and ≥99% purity is provided for every lot.
Independent third-party HPLC & mass-spec verification. The COA shipped with your order reflects your specific lot.
What is CJC-1295 DAC?
CJC-1295 with DAC is a GHRH analog carrying a Drug Affinity Complex that binds albumin for an extended half-life, studied for sustained GHRH-receptor activation in research models. It is research use only.
How does CJC-1295 DAC differ from the no-DAC version?
The DAC (Drug Affinity Complex) binds serum albumin, substantially extending circulating half-life in research models versus the no-DAC modified GRF 1-29.
What is CJC-1295 DAC\u2019s molecular weight?
CJC-1295 with DAC has an approximate molecular weight of 3,647.2 g/mol.